ReviewTranslational lung cancer research2015

Angiogenesis inhibition as a therapeutic strategy in non-small cell lung cancer (NSCLC).

Richard D Hall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.